Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Corticosteroids. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101891797B reveals a selective hydrolysis method for 17α-esters, offering high purity and yield for reliable steroid intermediate supply chains.
Patent CN101760495A details a non-toxic bio-route for steroid 1,2-dehydrogenation using Arthrobacter simplex, ensuring high purity and scalable manufacturing for global supply chains.
Patent CN100358914C details a novel one-step acetylation for Deflazacort production, offering significant cost reduction and improved purity for pharmaceutical intermediate manufacturing.
Patent CN101717428A details a green synthesis of Budesonide using acidic ionic liquids. This report analyzes the technical breakthroughs, cost reduction potential, and supply chain reliability for pharmaceutical manufacturers.
Patent CN104311625B reveals a cost-effective synthesis route for fluocinolone acetate intermediates, offering significant supply chain stability and purity advantages for pharmaceutical manufacturers.
Novel solid-base catalysis method for 16a-hydroxy prednisonlone production. Reduces impurities and cost. Reliable supply chain for budesonide manufacturing intermediates.
Patent CN102206696A reveals a scalable microbial route for 11,17α-substituted pregna-1,4-diene-3,20-dione. Achieve >97% purity and reduced manufacturing costs.
Patent CN101418029A reveals a cost-effective bromination route for methylprednisolone, offering high purity and scalable API intermediate manufacturing solutions.